Gut microbiota and sepsis-associated acute kidney injury: a narrative review - Report - MDSpire

Gut microbiota and sepsis-associated acute kidney injury: a narrative review

  • By

  • Hui Zhang

  • Bingling Fan

  • Ruze Ma

  • Ruowen Jiang

  • Zan Qin

  • Xueping Qu

  • Junwu Wang

  • Jiawei Xue

  • Caixia Wang

  • Xiaoqin Liu

  • Litao Guo

  • June 2, 2026

  • 0 min

Share

Clinical Report: The Role of Gut Microbiota in Acute Kidney Injury Related to Sepsis

Overview

This review highlights the significant role of gut microbiota dysbiosis in the development of sepsis-associated acute kidney injury (SA-AKI). It emphasizes the gut-kidney axis as a critical pathway influencing renal function during sepsis.

Background

Sepsis is a leading cause of organ dysfunction and mortality in ICU patients, with SA-AKI occurring in 40-50% of cases. Understanding the mechanisms linking gut dysbiosis and renal injury is crucial for developing targeted therapies. The gut-kidney axis suggests a bidirectional relationship where gut health impacts kidney function and vice versa.

Data Highlights

This review synthesizes findings from various studies on gut-kidney interactions in SA-AKI, focusing on microbial diversity and the impact of gut-derived metabolites on renal inflammation.

Key Findings

  • Sepsis induces gut dysbiosis, characterized by reduced microbial diversity and increased pathobionts.
  • Gut dysbiosis compromises intestinal barrier integrity, allowing bacterial products like lipopolysaccharide (LPS) to enter circulation.
  • Activation of the TLR4/NF-κB pathway leads to renal tubular injury and impaired function.
  • Specific microbial signatures associated with AKI include increased Clostridium asparagiforme and decreased Roseburia spp.
  • Gut-derived metabolites such as indoxyl sulfate and trimethylamine N-oxide (TMAO) contribute to renal inflammation and fibrosis.
  • Therapeutic strategies targeting the gut microbiota, including fecal microbiota transplantation and probiotic supplementation, may offer new avenues for treatment.

Clinical Implications

Clinicians should consider the role of gut health in managing patients with sepsis and SA-AKI. Interventions targeting gut microbiota may provide novel therapeutic options to mitigate renal injury in these patients.

Conclusion

The interplay between gut microbiota and kidney function is critical in SA-AKI, highlighting the potential for gut-targeted therapies in sepsis management.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- The gut-kidney axis in chronic kidney disease: a vicious cycle of microbial dysbiosis and uremic toxin accumulation
  2. Critical Care (Springer), 2025 -- Discovery of a resistant cohort to acute kidney injury: insights from patients with septic shock
  3. Frontiers in Endocrinology, 2026 -- The role of gut dysbiosis in endocrine and metabolic derangements of chronic kidney disease: mechanisms, controversies, and future perspectives
  4. Surviving Sepsis Campaign Adult Guidelines | SCCM, 2026
  5. Acute Kidney Injury (AKI) and Acute Kidney Disease (AKD) – KDIGO, 2026
  6. Nature Reviews Nephrology, 2023 -- Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup
  7. Frontiers in Immunology — Complement in acute kidney injury: a convergent pathogenic pathway in multifactorial renal damage
  8. Clinical background on sepsis-associated AKI and gut-kidney axis
  9. Acute Kidney Injury (AKI) and Acute Kidney Disease (AKD) – KDIGO
  10. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup | Nature Reviews Nephrology
  11. https://academic.oup.com/ajrccm/article-abstract/212/2/314/8435766
  12. A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis - PMC
  13. Frontiers | Gut microbiota and sepsis-associated acute kidney injury:a narrative review

Original Source(s)

Related Content